Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BSX | Common Stock | Options Exercise | $0 | +738 | +2.57% | $0.00 | 29.5K | Feb 15, 2022 | Direct | F1 |
transaction | BSX | Common Stock | Tax liability | -$11.4K | -259 | -0.88% | $44.01 | 29.2K | Feb 15, 2022 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BSX | Deferred Stock Units | Options Exercise | $0 | -738 | -49.97% | $0.00 | 739 | Feb 15, 2022 | Common Stock | 738 | Direct | F1, F2 | |
transaction | BSX | Restricted Stock Units | Award | $0 | +3.96K | $0.00 | 3.96K | Feb 16, 2022 | Common Stock | 3.96K | Direct | F3, F4 | ||
transaction | BSX | Stock Option (Right to Buy) | Award | $0 | +13.2K | $0.00 | 13.2K | Feb 16, 2022 | Common Stock | 13.2K | $44.19 | Direct | F5 |
Id | Content |
---|---|
F1 | Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
F2 | Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant. |
F3 | Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
F4 | Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant. |
F5 | Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant. |
monsonpoa.txt